Jay Lichter,Andrew M. Trammel,Fabrice Piu,Qiang Ye,Michael Christopher Scaife,Benedikt Vollrath,Sergio G. Duron,Luis A. Dellamary,Carl Lebel,Jeffrey P. Harris
申请号：
US15184183
公开号：
US20160310415A1
申请日:
2016.06.16
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with free-radical modulating agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
